PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Nov-2022 Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement Relief Therapeutics Holding SA
08-Nov-2022 Protein Expression Market - How The Market Will Witness Substantial Growth In The Upcoming Years Markets and Markets
08-Nov-2022 Humana Prices $1.25 Billion Debt Offering Businesswire
08-Nov-2022 Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order Businesswire
08-Nov-2022 AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase Businesswire
08-Nov-2022 Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting Businesswire
08-Nov-2022 Marinus Pharmaceuticals Announces Proposed Public Offering Businesswire
08-Nov-2022 Athersys, Inc. Announces Proposed Public Offering Businesswire
08-Nov-2022 Fabrinet Announces First Quarter Fiscal Year 2023 Financial Results Businesswire
08-Nov-2022 Invacare Reports Results for Third Quarter 2022 Businesswire
08-Nov-2022 CVD Equipment Corporation to Announce 2022 Third Quarter Results Businesswire
08-Nov-2022 NanoString Technologies Releases Operating Results for Third Quarter of 2022 Businesswire
08-Nov-2022 Xencor Reports Third Quarter 2022 Financial Results Businesswire
08-Nov-2022 Ligand Reports Third Quarter 2022 Financial Results Businesswire
08-Nov-2022 Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results Businesswire
07-Nov-2022 Merck, Synergis e IPS apresentam gestão de documentos de engenharia para conformidade e validação simplificadas Businesswire
07-Nov-2022 Merck, Synergis e IPS presentan la gestión de documentos de ingeniería para simplificar el cumplimiento y la validación Businesswire
07-Nov-2022 Merck, Synergis et IPS présentent la gestion des documents d'ingénierie pour simplifier les processus de conformité et de validation Businesswire
07-Nov-2022 Anumana Acquires NeuTrace, Establishing a Comprehensive Electrophysiology Deep-Learning Development Platform and Product Pipeline Businesswire
07-Nov-2022 MedinCell announces the initiation of Phase 3 study of F14 (mdc-CWM), a therapeutic first-in-class that aims to provide weeks of localized pain relief after Total Knee Replacement Businesswire